Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 ETF (NY:IWM)

209.20 +1.07 (+0.51%)
Streaming Delayed Price Updated: 12:43 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
TSS Stock Jumps On AI-fueled Q1 Results, Strong Guidance: Retail Exuberance Abounds
The company noted that procurement services revenue, making up over 90% of the total revenue, climbed 676%. 
Via Stocktwits
Topics Artificial Intelligence Earnings
Exposures Artificial Intelligence Financial
Market Monitor Trends (SPY, QQQ, IWM) and Breadth May 16
Short-term market trends remain bullish as strong breadth and rising moving average participation support the ongoing rally across U.S. indices. 
Via Chartmill
US Stock Futures Flatline As S&P 500 Looks To Finish Week On A High: Spotlight Turns To Consumer Sentiment Data
A fund manager expects corporate earnings momentum to continue, with a double-digit growth forecast for the remainder of the year. 
Via Stocktwits
Topics ETFs Economy Stocks
Exposures Fossil Fuels Interest Rates Tariff
Applied Materials Stock Retreats After Q2 Results Amid China Export Curb Concerns: Retail Reposes Faith In Chip-Equipment Maker
CEO Gary Dickerson said the company is well positioned at major technology inflections in fast-growing market areas, which supports its multi-year growth trajectory. 
Via Stocktwits
Topics Artificial Intelligence Earnings Government
Exposures Artificial Intelligence Financial Political
Wall Street Wavers As UNH Tumbles, Foot Locker Soars: What's Driving Markets Thursday?
U.S. stocks traded mixed Thursday, with major indices posting timid midday gains as investors digested fresh economic data revealing signs of consumer strain and disinflationary pressure stemming from... 
Via Benzinga
Topics World Trade
Exposures Tariff
Amneal Gets FDA Nod For Self-Administrable Migraine Injection
The company said the injection is the first and only dihydroergotamine (DHE) autoinjector for treating migraine and cluster headaches. 
Via Stocktwits
Topics Data Breach
Exposures Information Security Product Safety
Gambling.com Stock Dips Despite Q1 Earnings Beat
The company’s revenue jumped 39%, with marketing services and sports data services increasing 13% and 405% respectively. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Market Monitor Trends (SPY, QQQ, IWM) and Breadth May 15
While some longer-term measures still reflect strength, the short-term internal weakness suggests the market could be due for further consolidation or a deeper pullback, unless leadership broadens... 
Via Chartmill
Dow Futures Dip As Investors Brace For Powell's Remarks, Data Deluge: Strategist Warns of Fragile Bull Market
San Francisco Fed President Mary Daly said the economy is on solid footing and reinforced the central bank's ability to respond to any government initiatives. 
Via Stocktwits
Topics Artificial Intelligence Economy Immigration
Exposures Artificial Intelligence Economy Fossil Fuels
Tech Stocks Edge Up, AMD Rallies 5%, 30-Year Yields Eye Danger Zone: What's Driving Markets Wednesday?
Nasdaq 100 rises further as Nvidia and AMD rally on Middle East investment hopes, while gold tumbles and Treasury yields surge. 
Via Benzinga
Market Monitor Trends (SPY, QQQ, IWM) and Breadth May 14
Over the past several trading sessions, market breadth has shown a clear and encouraging shift toward strength, particularly in the short to medium term. 
Via Chartmill
US Stock Futures Edge Down After S&P 500 Erases 2025 Losses: Strategist Sees Possible Bottom But Warns Against Overexuberance
A fund manager expects huge amounts of investment funds and the fear of missing out to bring new buyers, especially if progress continues on the tariff front and the inflation impact is less than... 
Via Stocktwits
Topics Economy Government Stocks
Exposures Fossil Fuels Interest Rates Political
Candel Therapeutics Stock Jumps On Upbeat Q1 Earnings: Retail Gets More Bullish
The company reported diluted net income per share of $0.13 for the three months through the end of March, compared to a loss of $0.28 in the corresponding period of 2024. 
Via Stocktwits
Stocks Surge, Nvidia Rallies 5%, Oil Tops $63 After Trump's Iran Warning: What's Driving Markets Tuesday?
Wall Street's rally stretched into a second session Tuesday, fueled by improving investor sentiment after an early-week breakthrough in U.S.-China trade talks, easing inflation data and fresh... 
Via Benzinga
Topics Economy Government
Exposures Interest Rates Political
Altimmune Reports Better-Than-Feared Q1 Loss, Secures $100M Credit Facility: Retail’s Pleased
In the second quarter, the firm expects to announce data from a phase 2 trial of its investigational therapy, Pemvidutide, in treating metabolic dysfunction-associated steatohepatitis (MASH). 
Via Stocktwits
iTeos, GSK End Collaboration On Experimental Cancer Therapy Development: But Retail’s Extremely Bullish
The two companies worked together to assess the Belrestotug + Dostarlimab doublet in treating a specific type of lung cancer. 
Via Stocktwits
Topics Government
Exposures Political
The Best Russell 2000 ETF to Invest $500 In Right Now
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
AST SpaceMobile Stock Slips On Disappointing Q1: Retail Buyers Throng To Buy Dip In This Starlink Rival
CEO Abel Avellan said the company has expanded U.S. government opportunities and is positioned to start generating meaningful revenue in 2025. 
Via Stocktwits
Rigetti Falls On Q1 Miss But Retail Doubles Down On Stock Amid Faith In Quantum Computing Tech
Revenue fell about 52% year over year to $1.47 million, missing the Finchat-compiled consensus estimate of $2.55 million. 
Via Stocktwits
Topics Government
Exposures Political
Nasdaq, S&P 500 Futures Dip As Traders Pause For Breather Ahead Of April CPI: Strategist Sees Path To New Highs
Tariff news flow, first-tier economic data, and a few earnings reports could decide the day's trading direction, although the momentum is decisively in favor of further gains. 
Via Stocktwits
Topics Stocks
Exposures Fossil Fuels US Equities
Magnificent Seven Gain $700B After US-China Slash Tariffs, Gold Crashes: What's Driving Markets Monday?
Under the 90-day reprieve, the U.S. will cut tariffs on Chinese goods; Equities soared, but gold suffered its worst day since November. 
Via Benzinga
Topics World Trade
Exposures Tariff
Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens
The company also reiterated its full-year total revenue guidance of $250 million to $260 million and net product sales guidance of $240 million to $250 million. 
Via Stocktwits
Nasdaq, S&P 500 Futures Spike As Bessent Touts 'Substantial Progress' In China Trade Talks: Analyst Sees 'Huge' Positive For Markets
U.S. Trade Representative Jamieson Greer stated that the speed with which the U.S. and China could reach an agreement showed that perhaps the differences were not as large as initially thought. 
Via Stocktwits
Topics Economy Stocks World Trade
Exposures Fossil Fuels Interest Rates Tariff
Stocks Slip As Gold Rebounds To $3,330, Bitcoin Holds $102,000: What's Driving Markets Friday?
Wall Street traded slightly lower by midday Friday, as investors adopted a wait-and-see stance ahead of a potential trade breakthrough, with high-stakes negotiations between U.S. officials—led by... 
Via Benzinga
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish
CEO Shankar Musunuri said that the company is “on track” to meet its goal of submitting applications to the FDA requesting approval for the distribution of three of its products in the next three... 
Via Stocktwits
Topics Lawsuit
Exposures Financial Legal Product Safety
Verastem’s Combination Therapy For Ovarian Cancer Gets FDA Approval: Retail’s Pleased
The combination of Avutometinib capsules and Defactinib tablets, under the brand name Avmapki Fakzynja Co-pack, can now be used to treat patients with KRAS-mutated recurrent low-grade serous ovarian... 
Via Stocktwits
Exposures Product Safety
Novavax Stock Rallies On Upbeat Q1 Earnings, Revised Full-Year Revenue Forecast: Retail’s Elated
The company raised its full-year revenue guidance to between $975 million and $1.025 billion, up from its previous guidance of between $300 million and $350 million. 
Via Stocktwits
Exposures COVID-19 Product Safety
EVgo Reports Upbeat Q1 Earnings, CEO Expects Minimal Impact From Trump Tariffs: Retail’s Thrilled
The company also affirmed its full-year revenue guidance of $340 million to $380 million. 
Via Stocktwits
Topics Government World Trade
Exposures Political Tariff
Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says
U.S. stocks rallied Thursday after the Trump administration signed its first major trade agreement with the United Kingdom, igniting optimism about further global deals — especially with China — and... 
Via Benzinga
Topics Government
Exposures Political
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET. 
Via Benzinga
Topics Economy
Exposures Interest Rates
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.